in this issue
Regions :: North America :: U.S.
Merck to License Codexis Technology
1:59 PM MDT | August 6, 2007 | Chemical Week Editorial Staff
Codexis (Redwood City, CA) says it has entered into an agreement with Merck, under which Merck will gain non-exclusive access to Codexis’s biocatalysts for in-house screening. Financial details were not disclosed. Codexis says it has developed sets of diagnostic enzymes optimized for pharmaceutical manufacturing that partners can use internally to screen for reactivity in desired process...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee